Thursday broker round-up UPDATE
10th Oct 2013 08:36
Ashmore Group: Canaccord Genuity takes target price from 380p to 400p and retains a hold recommendation. Numis shifts target price from 380p to 390p reiterating its hold recommendation. Ashtead Group: Numis upgrades to add with a target price of 670p. Berkeley Group: Panmure Gordon moves target pr
Read moreImmunodiagnostic Systems returns to growth in first half
10th Oct 2013 08:32
Faster revenue growth from its automatic diagnostic testing technology helped Immunodiagnostic Systems (IDS) return to growth in the first half, with first-half declines in its older manual devices also slower than expected. IDS said total revenues for the six months to September 30th would swell
Read moreAshtead execs sell off awards after share-price surge
2nd Jul 2013 15:41
Equipment rental business Ashtead has seen a number of board-members sell off their share awards given to them as part of their performance share plan (PSP) in June 2010. Awards given to executives under the PSP vest on the third anniversary of grant subject to continued employment and the achievem
Read moreImmunodiagnostic Systems revenues shrink
17th Jun 2013 07:33
Immunodiagnostic Systems posted reduced revenues, in the wake of tough trading conditions, as it puts in place a strategy to return the group to growth. The Newcastle-upon-Tyne based group, which makes manual and automated specialist diagnostic testing kits and instrumentation for the clinical and
Read moreMonday broker round-up UPDATE
17th Jun 2013 07:21
Antofagasta: UBS reduces target price from 1140p to 1050p, while upgrading from neutral to buy. ARM Holdings: Analysts at Numis have cut their view on the shares to reduce from hold. Associated British Foods: Nomura cuts target price from 1800p to 1650p downgrading to reduce. Atkins: Jefferies u
Read moreWednesday broker round-up UPDATE
12th Jun 2013 07:55
Aberdeen Asset Management: Canaccord Genuity cuts target price from 460p to 440p, while leaving its buy recommendation unchanged. ASOS: Canaccord Genuity downgrades to hold with a target price of 3400p. BT Group: Credit Suisse increases target price from 300p to 350p and maintains an outperform ra
Read moreWednesday broker round-up UPDATE
10th Apr 2013 08:57
African Barrick Gold: Westhouse Securities upgrades from sell to neutral with a target price of 195p. Deutsche Bank reduces target price from 340p to 230p keeping its hold rating. African Minerals: Deutsche Bank reduces target price from 620p to 594p and leaves its buy recommendation unaltered. An
Read moreIDS update proves resilience and cash generation
10th Apr 2013 08:53
Revenues from medical diagnostics group Immunodiagnostic Systems to the end of March will be marginally reduced on the previous year but in line with expectations. In a year-end trading update, the Newcastle-upon-Tyne based company said total revenues would hit £49.8m for the year to March 31st, d
Read moreBelvoir Lettings Chairman sells shares to satisfy institutional demand
5th Apr 2013 16:55
Belvoir Lettings, the UK lettings specialist which listed on the AIM market in February last year, announced on Friday that its Executive Chairman and founder had sold a quarter of a million shares in the group in order to help satisfy 'significant institutional demand'. The news comes just a week
Read moreImmunodiagnostic Systems in collaboration with Diagnostica Stago
11th Feb 2013 14:25
Immunodiagnostic Systems (IDS), which produces manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, has unveiled what it described as a 'significant collaboration' with Diagnostica Stago, a French-based producer of coagulation and haemost
Read moreMonday broker round-up UPDATE
26th Nov 2012 07:18
Aberdeen Asset Management: Peel Hunt downgrades to hold, target price rises to 365p from 350p. Associated British Food: Investec raises target price from 1300p to 1400p, hold recommendation maintained. Barclays: JP Morgan raises target price from 250p to 320p and upgrades to overweight. Beazley:
Read moreImmunodiagnostic lowers revenue guidance
14th Sep 2012 14:13
Immunodiagnostic Systems (IDS), a producer of manual and automated specialist diagnostic testing kits, reported a decline in unaudited revenues for the five months ended August 31st. Turnover was down to £19.9m from £22.7m in the same period the previous year, partly the result of an adverse £0.5m
Read moreWednesday broker round-up -UPDATE
29th Aug 2012 09:38
888 Holdings: Investec upgrades from sell to buy target hiked from 18p to 95p. Advanced Medical Solutions: Singer Capital Markets upgrades to buy, target lifted from 80p to 82p. AstraZeneca: AlphaValue downgrades to reduce. Bunzl: Jefferies raises target from 835p to 860p, underperform rating kep
Read moreImmunodiagnostic Systems waves goodbye to CEO
25th Jun 2012 12:54
Immunodiagnostic Systems, a producer of manual and automated specialist diagnostic testing kits, has announced the immediate departure of its Chief Executive Officer, Ian Cookson. The company said it is now looking for a candidate who has "substantial diagnostic and international industry experien
Read moreThursday broker round-up
21st Jun 2012 09:13
ARM Holdings: Investec maintains buy rating and 800p target. Ashtead: Jefferies ups target from 300p to 320p, buy rating retained. Bellway: Goldman Sachs downgrades to neutral. British Land: Societe Generale downgrades to sell. CRH: HSBC upgrades to overweight. Dignity: Goldman Sachs downgrades
Read more